12.D.4 International issues of using GMOs to
control vertebrates
This project reviewed
international issues of using genetically modified organisms (GMOs)
as biological controls for vertebrates. The published report and
associated Wildlife Research article (see ‘Documents’)
provide a comprehensive and up-to-date overview of research on GMOs
in Australia and overseas. The regulations and ethics guidelines
presently governing this type of research are outlined. Important
issues concerning GMOs that have been raised in recent conferences
and literature are also described.
GMOs have been researched for
their potential in managing rabbits, mice, possums, foxes and
exotic fish. In Australia, the Invasive Animals CRC and its
predecessor the Pest Animal Control CRC had projects developing
fox, rabbit and mouse viruses for use as biocontrols. These
projects have since been shelved due to problems with lack of host
specificity or poor viral transmission. Despite these setbacks,
biocontrol remains an attractive option. A major IA CRC project
developing ‘daughterless’ carp (where GM carp only
produce male offspring) is underway. Interest has also recently
been shown in developing GMOs to control cane toads in
Australia.
Overseas, New Zealand is
developing a transmissible GM nematode targeted at possum
fertility, to greatly reduce the introducedpossum populations
there. In the United States, GMOs are being investigated to control
various exotic fish, using daughterless technology and other
strategies. In Spain, a transmissible GM virus aimed at protecting
native rabbits from both myxomatosis and rabbit hemorrhagic disease
(RHD) has been developed and field trialled. There is support for
this virus to be released, since the rabbit is valued for hunting,
and as prey for the endangered Iberian lynx and Spanish Imperial
eagle.
Regulations governing the research
and release of such GM biocontrols differ considerably in content
and stringency from country to country. Various levels of
regulations and guidelines also exist, from individual institutions
to federal governments and international agreements. International
agreements include the:
- Convention on Biological Diversity
- International Plant Protection Convention
- World Trade Organization’s Sanitary and Phytosanitary
Agreement
- requirements of the World Organisation for Animal Health.
There is currently some confusion about the relevance and
authority of some of these national and international instruments.
It is not clear what steps researchers need to take during the
development of GM biocontrols.
Concerns of using biocontrol GMOs,
particularly disseminating organisms, have been raised in the
recent literature and at two key conferences: the 2003
International Wildlife Management Congress in New Zealand and an
online conference hosted by the Convention of Biological Diversity
in 2004. The main concerns include:
-
harm to valued native populations
caused by the introduction (unintentional or otherwise) of GMOs
originally designed to eradicate or reduce that animal in another
country—for example, if the possum nematode from New Zealand
entered Australia
-
risks of a GMO designed to
preserve a species in one country compromising pest-control
programs in another—for example, if the Spanish rabbit
RHD/myxomatosis vaccine entered Australia
-
host specificity and safety of GM
biocontrol agents
-
the need for an international body
to consult with and regulate the use of biocontrol GMOs.
Authors Dr Wendy Henderson
(University of Canberra) and Dr Elaine Murphy (Department of
Conservation, New Zealand) are both passionate about the need for
transparent and careful research with biocontrol GMOs. Elaine
helped organise the 2004 online conference through the Biosafety
Clearance House. “These issues need to be openly recognised
and discussed by researchers and decision makers alike”, she
says. "If you are developing a new pest control technique that
could adversely affect the biodiversity of another country, at what
point do you consult with that country? Who do you consult? The
process, and who takes responsibility, is not that clear."
“The development of
biocontrol GMOs that affect reproduction or immune responses could
provide a sophisticated solution to a particular country’s
problems”, says Wendy. “But this type of research is
expensive, lengthy and contentious. It’s certainly not
guaranteed of success—the CRCs’ recent research on
mouse, fox and rabbit control showed that. We need to be incredibly
careful about the type of GMO we release, and think about how it
would affect other countries as well as our own. Once it’s
out, it’s out.”
The report shows support among
researchers, politicians and community members for a precautionary
approach and for international consultation. But how should this
consultation take place? When is a GMO safe enough to be released?
Who should decide these things? It is hoped the report will
stimulate further discussion of these questions, to clarify and
improve on the current situation.